Wall Street Analysts See a 51.94% Upside in Carlsmed, Inc. (CARL): Can the Stock Really Move This High?
Carlsmed, Inc. (CARL) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Wall Street Analysts Think Carlsmed, Inc. (CARL) Could Surge 90.77%: Read This Before Placing a Bet
Here's What Analysts Are Forecasting For Carlsmed, Inc. (NASDAQ:CARL) After Its First-Quarter Results
Carlsmed Q1 Earnings Call Highlights
Carlsmed, Inc. (CARL) Q1 2026 Earnings Call Transcript
Carlsmed, Inc. (CARL) Reports Q1 Loss, Tops Revenue Estimates
Carlsmed (CARL) Q1 2026 Earnings Transcript
Carlsmed (NASDAQ:CARL) Shares Surge on Q1 Earnings Beat and Raised Full-Year Guidance
Carlsmed® Reports First Quarter 2026 Financial Results
Carlsmed Q1 2026 Earnings Call: Complete Transcript
Carlsmed Raises FY2026 Sales Guidance from $70.000M-$75.000M to $72.000M-$77.000M vs $72.807M Est
Carlsmed Q1 EPS $(0.32) Beats $(0.41) Estimate, Sales $16.100M Beat $14.984M Estimate
Carlsmed, Inc. To Participate in Upcoming Investor Conferences
Truist Securities Maintains Buy on Carlsmed, Lowers Price Target to $18
Carlsmed Inc. to Report First Quarter 2026 Financial Results on May 5, 2026
Carlsmed Showcases Personalized Spine Fusion Gains, Cervical Expansion and Medicare Tailwinds at Needham Conf
Goldman Sachs Maintains Buy on Carlsmed, Lowers Price Target to $17
Carlsmed Inc (NASDAQ:CARL) Reports Q4 Revenue Beat and Narrower-Than-Expected Loss
Carlsmed, Inc. (CARL) Q4 2025 Earnings Call Transcript
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.